Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof
US9206402B2 · kind B2 · utility
9Cited by
2References
24Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 15, 2012 |
| Grant date | Dec 8, 2015 |
| Priority date | — |
| Expiry date | Nov 26, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y301/06013
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a composition comprising recombinant iduronate-2-sulfatase (IDS). The glycosylation pattern and formylglycine content of the IDS composition are different from those of Elaprase and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter syndrome.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.